Omega-3 fatty acids protect cartilage from acute injurie by reducing the mechanical sensitivity of chondrocytes

Fan Chen, Zian Zhang, Wenzhe Wang, Chang Liu, Zhenchao Huang, Chaoqun Yu, Zhen Jia, Haining ZhangJournal of Orthopaedic Surgery and Research 2024 · DOI

Abstract

Acute cartilage injuries, such as intra-articular fractures and blunt impacts, frequently result in chondrocyte death and extracellular matrix (ECM) degradation, significantly elevating the risk of post-traumatic osteoarthritis (PTOA). Despite advances in treatment, no effective therapies currently exist to fully cure PTOA or halt its progression. This study explores the protective effects of the dietary fatty acid eicosapentaenoic acid (EPA) on human primary chondrocytes (HPCs) and cartilage explants exposed to mechanical overload and blunt trauma. EPA treatment markedly decreased chondrocyte mechanical sensitivity, as demonstrated by enhanced cell viability and reduced lactate dehydrogenase (LDH) release. Furthermore, EPA inhibited Piezo1 activation, leading to lower intracellular Ca²⁺ concentrations, decreased apoptosis, and diminished ROS levels. These results indicate that EPA effectively shields chondrocytes and cartilage explants from mechanical overload-induced damage by inhibiting Piezo1 activation and mitigating Ca²⁺ influx, apoptosis, and oxidative stress. The findings suggest that EPA supplementation could offer a promising strategy for preventing PTOA progression following acute cartilage injuries.

Introduction

Acute cartilage injuries from sports impacts or accidents often trigger a degenerative cascade leading to post-traumatic osteoarthritis (PTOA). When cartilage is crushed or overstretched, resident chondrocytes sense this mechanical stress through specialized ion channels. Extreme force causes these channels—specifically Piezo1—to overreact, leading to a massive influx of calcium ($Ca^{2+}$), the production of reactive oxygen species (ROS), and programmed cell death (apoptosis). Currently, no clinical "reset button" exists for this process. This study investigates whether eicosapentaenoic acid (EPA), an omega-3 fatty acid, can physically modulate how chondrocytes perceive and react to mechanical overload, potentially acting as a preventative therapy.

Methodology

The researchers employed a multi-scale experimental approach using human tissue:

  • Cellular Level: Human primary chondrocytes (HPCs) were isolated from knee surgery patients, seeded onto flexible silicone membranes, and subjected to a 33% mechanical stretch to simulate traumatic deformation.
  • Tissue Level: Cartilage explants (6mm) were subjected to a controlled 0.56 J impact using a customized drop tower to mimic blunt trauma.
  • Intervention: Samples were pre-treated with 100 µM EPA.
  • Analysis: Real-time intracellular calcium levels were tracked via Fluo-4 AM imaging, while ROS and apoptosis were quantified through flow cytometry. Structural integrity was assessed via Collagen Type II (Col-2a) expression.

Results

Piezo1 and Calcium Modulation

The study identified Piezo1 as the primary mechanical sensor. Mechanical deformation opens Piezo1, allowing $Ca^{2+}$ to flood the cell. EPA treatment significantly blunted this influx. By integrating into the cell's lipid bilayer, EPA likely alters membrane fluidity, making it harder for mechanical force to trigger the Piezo1 channel and accelerating its inactivation.

Cellular Protection and Viability

In the 33% stretch model, EPA significantly improved cell survival. As shown in the experimental data, stretching causes a significant increase in cell area and metabolic markers of damage (such as LDH release), which EPA treatment effectively mitigated.

Figure 6: Experimental analysis of HPCs under mechanical stretch. (A-B) Morphological changes and cell area increases during stretching. (C) EPA shows no adverse effect on normal cell growth. (D-E) EPA reduces the surge in fluorescence intensity (ROS/Calcium) caused by stretching. (F) EPA reduces the release of damage markers (OD 490nm) compared to the stretch-only group.

Oxidative Stress and Matrix Preservation

EPA-treated cells showed no significant increase in ROS levels after stretching, whereas untreated stretched cells experienced a major surge. Beyond survival, EPA helped chondrocytes maintain their phenotype by preventing the typical post-injury drop in Collagen Type II production, which is essential for long-term joint structural integrity.

Discussion and Conclusion

The findings suggest that EPA "tunes down" the mechanical sensitivity of chondrocytes, offering a potential dietary strategy to prevent PTOA. By inhibiting the toxic calcium overload and oxidative stress following joint impact, EPA protects both the cells and the surrounding extracellular matrix.

While promising, this study was conducted in vitro. The complex environment of a living joint—including synovial fluid and systemic inflammation—may influence EPA's effectiveness. Future research is required to determine optimal clinical dosages and the "window of opportunity" for treatment following an acute injury. Nonetheless, EPA supplementation represents a low-risk, high-potential intervention for patients at risk of post-traumatic joint degeneration.

Summary updated

Abstract

Acute cartilage injuries, such as intra-articular fractures and blunt impacts, frequently result in chondrocyte death and extracellular matrix (ECM) degradation, significantly elevating the risk of post-traumatic osteoarthritis (PTOA). Despite advances in treatment, no effective therapies currently exist to fully cure PTOA or halt its progression. This study explores the protective effects of the dietary fatty acid eicosapentaenoic acid (EPA) on human primary chondrocytes (HPCs) and cartilage explants exposed to mechanical overload and blunt trauma. HPCs were isolated and subjected to mechanical stretching using BioFlex six-well culture plates, while cartilage explants were subjected to impact loading via a customized drop tower. EPA was incorporated into the culture medium, followed by assays to evaluate cell viability, calcium (Ca²⁺) influx, apoptosis, reactive oxygen species (ROS) levels, and collagen type II alpha (Col-2a) expression. EPA treatment markedly decreased chondrocyte mechanical sensitivity, as demonstrated by enhanced cell viability and reduced lactate dehydrogenase (LDH) release. Furthermore, EPA inhibited Piezo1 activation, leading to lower intracellular Ca²⁺ concentrations, decreased apoptosis, and diminished ROS levels. In cartilage explants, EPA improved chondrocyte viability, minimized structural damage, and sustained higher Col-2a expression compared to the blunt trauma group. These results indicate that EPA effectively shields chondrocytes and cartilage explants from mechanical overload-induced damage by inhibiting Piezo1 activation and mitigating Ca²⁺ influx, apoptosis, and oxidative stress. The findings suggest that EPA supplementation could offer a promising strategy for preventing PTOA progression following acute cartilage injuries. Further research is warranted to assess the clinical applications of EPA and confirm its efficacy in larger animal models and human trials.
BibTeX
@article{chen2024omega,
  author = {Fan Chen and Zian Zhang and Wenzhe Wang and Chang Liu and Zhenchao Huang and Chaoqun Yu and Zhen Jia and Haining Zhang},
  title = {{Omega-3 fatty acids protect cartilage from acute injurie by reducing the mechanical sensitivity of chondrocytes}},
  journal = {Journal of Orthopaedic Surgery and Research},
  year = {2024},
  doi = {10.1186/s13018-024-05081-4},
}
Figure